老花眼矫正植入器材市场规模、份额及成长分析:按类型、器材、材料、年龄层、最终用户和地区划分-2026-2033年产业预测
市场调查报告书
商品编码
2003836

老花眼矫正植入器材市场规模、份额及成长分析:按类型、器材、材料、年龄层、最终用户和地区划分-2026-2033年产业预测

Implantable Presbyopia Correction Devices Market Size, Share, and Growth Analysis, By Type (Corneal Inlays, Scleral Implants), By Device Type, By Material, By Age Group, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2024 年全球老花眼矫正植入市场价值为 99 亿美元,预计到 2025 年将成长至 113.9 亿美元,到 2033 年将成长至 351 亿美元,在预测期(2026-2033 年)内复合年增长率为 15.1%。

老花眼矫正植入式设备市场的主要驱动力是人口老化。随着预期寿命的延长,老年人对摆脱眼镜的需求日益增长。该市场涵盖各种外科植入,例如人工水晶体和角膜嵌体,这些植入物对于改善近距离和中距离视力至关重要,并能够显着提高患者的整体生产力和生活品质。随着治疗方式从依赖眼镜转向手术干预,水晶体设计和手术技术的进步至关重要。技术创新正在提升手术过程中的光学性能和引导效果,从而提高患者满意度,并促使医疗专业人员推荐高端设备。此外,人工智慧的整合提高了诊断准确性,实现了个人化的手术方案製定和优化的治疗效果,进一步促进了全球市场的发展和成长,尤其是在白内障病例不断增加的新兴国家。

推动全球老花眼矫正植入市场发展的因素

患者对摆脱眼镜的渴望日益增长,显着影响了老花眼矫正手术中人工水晶体的应用。这一趋势迫使医疗机构引入能够有效改善近距离和远视的手术治疗方法。随着患者越来越重视便利性和生活品质的提升,对这些解决方案的需求不断增长,促使医疗机构拓展服务范围,并投资必要的培训和设备。满意的患者常常共用他们的积极体验,这不仅促进了人工晶体的普及,也鼓励外科医生在实践中采用这些创新设备,从而透过加强临床整合和以患者主导中心的服务,推动永续增长。

全球植入式老花眼矫正设备市场面临的限制因素

全球老花眼矫正植入式设备市场成长受到报销和保险覆盖范围差异等问题的限制。这些因素给患者带来沉重的经济负担,也为考虑投资专用设备和必要培训的医疗机构带来不确定性。当保险公司将老花眼矫正归类为「择期手术」时,临床医生难以获得稳定的报销,患者则面临高额的自付费用,从而阻碍了该疗法的普及。这种情况阻碍了医疗系统对这些治疗方法的广泛应用,最终导致转诊减少和治疗选择受限。因此,这也影响了製造商和服务供应商拓展产品线的意愿。

全球老花眼矫正植入市场趋势

全球老花眼矫正植入物市场正呈现出向个人化植入解决方案发展的显着趋势。製造商和临床医生正优先考虑可客製化的设计和可调节的光学系统,以满足老花眼患者独特的视觉需求和生活方式偏好。这项转变的特点是模组化组件的集成,从而实现手术调整和使用患者特异性生物相容性材料,进而提升治疗效果的感知度并提高患者满意度。随着对个人化治疗方案的日益重视,设备开发商、眼科医师和病患权益组织之间的合作日益加强,推动了创新和知情决策。这有助于增强品牌忠诚度,并在竞争激烈的市场环境中维持临床信誉。

目录

介绍

  • 调查目的
  • 市场定义和范围

调查方法

  • 研究过程
  • 二级资料和一级资料的方法
  • 市场规模估算方法

执行摘要

  • 全球市场展望
  • 市场主要亮点
  • 细分市场概览
  • 竞争环境概述

市场动态及展望

  • 总体经济指标
  • 促进者和机会
  • 抑制因素和挑战
  • 供给面趋势
  • 需求面趋势
  • 波特的分析和影响

关键市场分析

  • 关键成功因素
  • 影响市场的因素
  • 主要投资机会
  • 生态系测绘
  • 2025年市场魅力指数
  • PESTLE分析
  • 监理情势

全球老花眼矫正植入设备市场规模:依类型划分

  • 角膜嵌体
  • 巩膜植入

全球老花眼矫正植入设备市场规模:依设备类型划分

  • 单焦点植入
  • 多焦点植入
  • 环形植入

全球老花眼矫正植入设备市场规模:依材料划分。

  • 硅酮
  • 丙烯酸纤维

全球老花眼矫正植入设备市场规模:依年龄层划分

  • 40-50岁
  • 50-65岁
  • 65岁或以上

全球老花眼矫正植入设备市场规模:依最终用户划分

  • 医院和诊所
  • 门诊手术中心

全球老花眼矫正植入设备市场规模:依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太国家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲国家

竞争资讯

  • 前五大公司对比
  • 主要企业2025年的市场定位
  • 主要市场公司采取的策略
  • 近期市场趋势
  • 企业市场占有率分析,2025 年
  • 主要企业的完整公司简介
    • 公司详情
    • 产品系列分析
    • 按细分市场进行企业市占率分析
    • 销售收入年比比较(2023-2025 年)

主要企业简介

  • AcuFocus, Inc.
  • Alcon Vision LLC
  • ReVision Optics
  • LifePoint Health
  • Bausch+Lomb
  • Vortecia
  • Allergan, a subsidiary of AbbVie
  • Eyepoint Pharmaceuticals
  • Croma Pharma GmbH
  • Vision Solutions, Inc.
  • Presbyopia Therapy, Inc.
  • Eyetec, Inc.
  • Shringrix Technologies
  • Ocular Dynamics
  • Dextina Health
  • Solos Endoscopy
  • Presbia PLC
  • 4D Vision
  • Insight Vision
  • Adaptica Srl

结论与建议

简介目录
Product Code: SQMIG35A3307

Global Implantable Presbyopia Correction Devices Market size was valued at USD 9.9 Billion in 2024 and is poised to grow from USD 11.39 Billion in 2025 to USD 35.1 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The implantable presbyopia correction devices market is primarily driven by an aging demographic, as increased life expectancy amplifies the demand for independence from spectacles among older adults. This market includes various surgical implants, such as intraocular lenses and corneal inlays, critical for enhancing near and intermediate vision, which significantly impacts overall productivity and quality of life. As the sector shifts from reliance on spectacles to surgical interventions, technological advancements in lens design and surgical techniques become essential. Innovations foster improved optics and guidance during procedures, raising patient satisfaction and encouraging clinician recommendations for premium devices. Additionally, the integration of AI enhances diagnostic accuracy, customizes surgical planning, and optimizes outcomes, further fueling engagement and growth globally, particularly in emerging economies with increasing cataract cases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Presbyopia Correction Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Presbyopia Correction Devices Market Segments Analysis

Global implantable presbyopia correction devices market is segmented by type, device type, material, age group, end user and region. Based on type, the market is segmented into Corneal Inlays and Scleral Implants. Based on device type, the market is segmented into Monofocal Implants, Multifocal Implants and Toric Implants. Based on material, the market is segmented into Silicone and Acrylic. Based on age group, the market is segmented into Age 40-50, Age 50-65 and Age above 65. Based on end user, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Presbyopia Correction Devices Market

The growing desire among patients for independence from spectacles is significantly influencing the adoption of implantable presbyopia correction devices. This trend prompts healthcare providers to introduce surgical alternatives that effectively enhance both near and distance vision. As patients increasingly focus on convenience and improving their overall quality of life, the demand for these solutions propels providers to broaden their service offerings and invest in necessary training and equipment. Satisfied patients often share their positive experiences, which not only boosts acceptance but also encourages surgeons to adopt these innovative devices in their practices, fostering a sustainable growth trajectory through enhanced clinical integration and consumer-driven services.

Restraints in the Global Implantable Presbyopia Correction Devices Market

The growth of the global implantable presbyopia correction devices market is hindered by challenges related to reimbursement and varying insurance coverage. These factors impose a heavy financial burden on patients and create uncertainty for healthcare providers who are contemplating investments in specialized devices and the necessary training. When insurance companies categorize presbyopia correction as an elective procedure, it hampers adoption rates, as clinicians struggle to secure consistent compensation while patients are faced with high out-of-pocket costs. This situation discourages health systems from widely implementing these treatments, ultimately decreasing referral volumes and limiting access to options, which in turn affects manufacturers' and service providers' willingness to diversify their offerings.

Market Trends of the Global Implantable Presbyopia Correction Devices Market

The Global Implantable Presbyopia Correction Devices market is witnessing a significant trend toward personalized implant solutions. Manufacturers and clinicians are prioritizing customizable designs and adjustable optics tailored to the unique visual requirements and lifestyle preferences of presbyopic individuals. This shift is characterized by the integration of modular components, allowing for surgeon-controlled adjustments, and the use of patient-specific biocompatible materials to improve perceived outcomes and enhance patient satisfaction. The growing emphasis on individualized treatment pathways fosters collaboration among device developers, ophthalmic surgeons, and patient advocates, driving innovation and informed decision-making, ultimately strengthening brand loyalty and maintaining clinical credibility in a competitive landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Implantable Presbyopia Correction Devices Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Corneal Inlays
  • Scleral Implants

Global Implantable Presbyopia Correction Devices Market Size by Device Type & CAGR (2026-2033)

  • Market Overview
  • Monofocal Implants
  • Multifocal Implants
  • Toric Implants

Global Implantable Presbyopia Correction Devices Market Size by Material & CAGR (2026-2033)

  • Market Overview
  • Silicone
  • Acrylic

Global Implantable Presbyopia Correction Devices Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Age 40-50
  • Age 50-65
  • Age above 65

Global Implantable Presbyopia Correction Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Clinics
  • Ambulatory Surgical Centers

Global Implantable Presbyopia Correction Devices Market Size & CAGR (2026-2033)

  • North America (Type, Device Type, Material, Age Group, End User)
    • US
    • Canada
  • Europe (Type, Device Type, Material, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Device Type, Material, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Device Type, Material, Age Group, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Device Type, Material, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • AcuFocus, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon Vision LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ReVision Optics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifePoint Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch + Lomb
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vortecia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allergan, a subsidiary of AbbVie
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eyepoint Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croma Pharma GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vision Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Presbyopia Therapy, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eyetec, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shringrix Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ocular Dynamics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dextina Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solos Endoscopy
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Presbia PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 4D Vision
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insight Vision
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Adaptica Srl
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations